title: [Guillain-Barré syndrome in patients treated for Hodgkin disease].
abstract: BACKGROUND
  A 14-year-old boy treated with Hodgkin's disease developed muscular weakness and pain, hypotonia, abolished deep tendon reflexes. Examination of the cerebrospinal fluid showed albuminocytologic dissociation, the characteristic finding of Guillain-Barré syndrome. After high dose steroid treatment complete recovery occurred.
  
  
  CONCLUSIONS
  Paraneoplastic neuropathies may develop in patients with cancer, Guillain-Barré syndrome occurs in patients with active Hodgkin's disease.
  
  
  CONCLUSIONS
  Progressive neurological signs may indicate the presence of a malignancy, or in case of chemotherapy shows the activity of the tumour.
authors.affiliation: Fóvárosi Onkormányzat Heim Pál Gyermekkórház, Hematológiai Osztály, Budapest.
authors.forename: Enikö
authors.initials: E
authors.lastname: Apjok
authors.forename: Anikó
authors.initials: A
authors.lastname: Marosi
authors.forename: Edina
authors.initials: E
authors.lastname: Magyarosy
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy / Q000209:etiology*; D006689:Hodgkin Disease / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D020361:Paraneoplastic Syndromes, Nervous System / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D018696:Neuroprotective Agents; D008776:Methylprednisolone Hemisuccinate